Advertisement

Topics

FDA committee to review Clarus' hypogonadism therapy

04:46 EST 9 Jan 2018 | SmartBrief

An FDA committee on Tuesday will discuss Clarus Therapeutics' marketing application for Jatenzo, a testosterone replacement d -More

Original Article: FDA committee to review Clarus' hypogonadism therapy

NEXT ARTICLE

More From BioPortfolio on "FDA committee to review Clarus' hypogonadism therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Endocrinology
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...